Octagon Capital Advisors LP Chemo Centryx, Inc. Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$9.59 - $50.88 $1.44 Million - $7.64 Million
-150,076 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$49.53 - $68.4 $3.71 Million - $5.13 Million
-75,000 Reduced 33.32%
150,076 $7.69 Million
Q4 2020

Feb 16, 2021
BUY
$47.25 - $65.16 $10.6 Million - $14.7 Million
225,076 New
225,076 $13.9 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email